“Aggressive transition to higher visual acuity treatments”: Amedisys’ future after CEO change

This article is part of your HHCN+ membership.

Amedisys Inc. (Nasdaq: AMED) new CEO. With the change of power, we will probably learn a lot about what the future of the company looks like.

As one of the largest independent nursing care providers in the country, the next steps for Amedisys will impact all areas of home healthcare and hospices. And it’s becoming clearer every day that the Amedisys of the past 10 years will not be the Amedisys of tomorrow.

Subscribe to HHCN+ to read this exclusive content.

Individual membership $400 per year


Group 2–5 members $380 per year*


Need more than 5 participants? For more information please contact us.

* per member

Already entered?

Content Source

California Press News – Latest News:
Los Angeles Local News || Bay Area Local News || California News || Lifestyle News || National news || Travel News || Health News

Related Articles

Back to top button